R-IMPP
CAS No. 2133832-83-2
R-IMPP ( —— )
Catalog No. M17432 CAS No. 2133832-83-2
R-IMPP is an inhibitor of PCSK9 translation. R-IMPP stimulates uptake of LDL-C in hepatoma cells by increasing LDL-R levels, without altering levels of secreted transferrin.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 49 | Get Quote |
|
5MG | 77 | Get Quote |
|
10MG | 135 | Get Quote |
|
25MG | 281 | Get Quote |
|
50MG | 500 | Get Quote |
|
100MG | 718 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameR-IMPP
-
NoteResearch use only, not for human use.
-
Brief DescriptionR-IMPP is an inhibitor of PCSK9 translation. R-IMPP stimulates uptake of LDL-C in hepatoma cells by increasing LDL-R levels, without altering levels of secreted transferrin.
-
DescriptionR-IMPP is an inhibitor of PCSK9 translation. R-IMPP stimulates uptake of LDL-C in hepatoma cells by increasing LDL-R levels, without altering levels of secreted transferrin.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorPCSK9
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number2133832-83-2
-
Formula Weight389.21
-
Molecular FormulaC24H27N3O2
-
Purity98%
-
SolubilityDMSO : ≥ 41 mg/mL; 105.27 mM
-
SMILESCOC1=CC=C(CCC(N(C2=C(C=CC=C3)C3=CC=N2)[C@H]4CNCCC4)=O)C=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Petersen DN., et al. A Small-Molecule Anti-secretagogue of PCSK9 Targets the 80S Ribosome to Inhibit PCSK9 Protein Translation. Cell Chem Biol. 2016 Nov 17;23(11):1362-1371.
molnova catalog
related products
-
Oxoglaucine
Oxoglaucine exerts immunomodulatory effect in vivo in a dose-dependent and protocol-dependent manner, it also exhibits significant antiplatelet aggregation activity against rabbit platelets induced by thrombin, arachidonic acid, collagen or platelet activating factor.
-
Luvangetin
Luvangetin may have anti-inflammatory activity, it can inhibit NO and PGE2 production in LPS-stimulated BV2 cells.
-
Tigloylgomisin P
Tigloylgomisin P shows moderate to marginal cytotoxicity against A549, PC-3, KB and KBvin human cancer cell lines.